Navigation Links
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Date:5/21/2009

NCE V and is based upon the proven design of the MULTI-LINK(R) family of stents. Abbott plans to make XIENCE PRIME available in an expanded size matrix, including XIENCE PRIME SV for small vessels and XIENCE PRIME LL for long lesions. XIENCE PRIME is pending CE Mark and is not available for sale.

"XIENCE PRIME builds upon the unprecedented body of clinical evidence from the SPIRIT family of clinical trials, and offers advances in the delivery system and an enhanced stent design to make the stent even easier for physicians to deliver to the lesion site," said Robert Hance, president, Abbott Vascular. "We are pleased with the progress we've made to bring this next advancement to physicians and patients, and we look forward to launching XIENCE PRIME in Europe later this year."

About XIENCE V

XIENCE V is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION stent. The VISION platform is designed to facilitate ease of delivery, making it easier for physicians to maneuver the stent and treat the diseased portion of the artery.

The XIENCE V stent is available on both over-the-wire (OTW) and rapid exchange (RX) delivery systems. Rapid exchange is the most widely used type of delivery system because it provides physicians additional flexibility to work as single operators during stent procedures.

Abbott's market-leading XIENCE V drug eluting stent is marketed in the United States, Europe and other international markets. XIENCE V is an investigational device in Japan and is currently under review by Japan's Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency. It is also under review with Health Canada. '/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
2. Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
3. Spirit II explores long-term performance of XIENCE V stent
4. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
5. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
6. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
7. Ted Karkus Admits to Financial Relationship With Dr. Richard A. Rosenbloom; Demonstrates Pattern of Improper Influence, Unethical Behavior, Falsification and Distortion; Company Questions What Else Karkus May Be Hiding From Shareholders
8. Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009
9. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
10. Ben-Gurion U of the Negev study demonstrates link between appetite and elderly mortality
11. New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Every year at this time, students prepare to ... are prepared to face the academic workload confronting them. They just don’t have the ... since schools don’t teach students how to study. , “Bankers bank. Salesmen sell. Teachers ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China ... international investment and business conference will be hosted at five star Beijing Kunlun ... full-weekend networking conference will feature leading EB-5 industry professionals and Chinese private equity ...
(Date:9/2/2015)... ... September 02, 2015 , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ... its negative impact on consumers. It was reported that 33% are paying an average ... much as an extra $100 compared to last year. Among the drugs that saw ...
(Date:9/2/2015)... ... September 02, 2015 , ... Amada Senior Care, premier provider of in-home care ... Johnson County location. Amada franchise partners Mike and Mell Fleming came to ... and spent over 20 years in medical device sales while Mell spent over 30 ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... engineer of patented products, announces Hand Free Pocket Cop, a safety invention that ... in the US is worth $31 billion," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... that polymerase chain reaction (PCR) testing for Borrelia burgdorferi ... may confirm the diagnosis of Lyme arthritis, but is ... patients whose arthritis persists after antibiotic therapy. Findings of ... , a journal of the American College of Rheumatology ...
... DENVER According to a new study conducted by researchers ... pulmonary disease (COPD) an effective workout and one that, ... "Our study showed that COPD patients exercised at ... five minutes of specified Wii Fitexercises, indicating the Wii Fit ...
... , MONDAY, May 16 (HealthDay News) -- A chemical ... may pose a health risk, a new study indicates. ... at levels of the chemical, isocyanic acid, in the ... chemical with conventional measurement techniques, explained the U.S. National ...
... , MONDAY, May 16 (HealthDay News) -- Asthma patients ... flares can suffer worse outcomes, including hospitalization. That,s ... patients in two New York City emergency departments. They ... and their attempts at self-management before they decided to ...
... Randy Dotinga HealthDay Reporter , MONDAY, May 16 (HealthDay ... infested by parasites despite clinical evidence to the contrary. Now, ... in the patient,s head -- is often right on target. ... bugs, worms or germs had invaded their skin. In all but ...
... an explanation of how stroke patients can achieve better recovery. ... has proved to benefit recovery during the later phases of ... a hormone that is found in the blood and contributes ... of this hormone are higher in people who exercise regularly ...
Cached Medicine News:Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 2Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 3Health News:COPD patients may breathe easier, thanks to the Wii 2Health News:COPD patients may breathe easier, thanks to the Wii 3Health News:Chemical in Smoke May Pose Health Risk 2Health News:Don't Delay Emergency Care When Asthma Flare-Ups Strike 2Health News:For Some, Bugs Crawling on Skin Is a Delusion 2Health News:Hormone improves long-term recovery from stroke 2
(Date:9/2/2015)... WASHINGTON , Sept. 2, 2015 /PRNewswire-USNewswire/ ... representing a broad spectrum of physicians who ... American Association of Clinical Endocrinologists, American College ... State Rheumatology Organizations, and North American Society ... sent a letter to Centers for Medicare ...
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of the "Pharmaceutical ... UAE - October 18-19, 2015)" conference to ... Ensuring Compliance with Regulatory Requirements Particularly ... QA and Document Management Functions & Regulatory Authorities ...
(Date:9/2/2015)... 2015   Voalte , the leader in healthcare ... $17 million by Ascension Ventures , Cerner Capital, ... Series D funding closed on July 27, 2015, bringing ... million in three years. The new capital ... for Voalte. The privately held company grew revenue by ...
Breaking Medicine Technology:Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 2Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 3Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 5Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 6Pharmaceutical Regulatory Affairs Course in the Middle East, Dubai (Dubai, UAE - October 18-19, 2015) 2Voalte Raises $17 Million in Series D Financing 2Voalte Raises $17 Million in Series D Financing 3Voalte Raises $17 Million in Series D Financing 4
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
... of Vision and Contrast Sensitivity. The ... and glare luminance levels for accurate ... with/without glare and background luminance Comply ... standards. All Light Levels Microprocessor Controlled ...
Medicine Products: